Short-term Changes in Self-rating Depression Scale Scores after Smoking Cessation in Neurotic Patients.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
15 Apr 2021
Historique:
pubmed: 16 10 2020
medline: 17 4 2021
entrez: 15 10 2020
Statut: ppublish

Résumé

Objective The psychological status is a key factor in smoking continuance. However, details on short-term changes in mild depressive states after smoking cessation (SC) are still unknown. The purpose of the present study was to investigate these short-term changes. Methods A total of 989 patients who visited our SC Clinic were assessed using the Zung Self-Rating-Depression-Scale (SDS), an official instrument to measure depressive tendencies. The participants were classified into normal and neurotic groups based on their SDS scores during their initial visit; they were assessed again 2, 4, 8, and 12 weeks thereafter. Results The majority of patients in the neurotic group were women. These patients were also younger, with a higher nicotine dependence, and presented with a lower successful SC rate than the patients in the normal group. A decrease in SDS scores after starting the SC treatment was observed only in the neurotic group, especially during the first two weeks. In patients who continued to smoke, no improvement in depressive tendencies was noted in this period. Conclusion Depressive tendencies of patients with neurosis improve in the initial stages of the SC treatment (i.e., within two weeks after starting the treatment). This finding fills the mentioned knowledge gap regarding the effects of SC on mild depressive states in the short term.

Identifiants

pubmed: 33055476
doi: 10.2169/internalmedicine.4868-20
pmc: PMC8112982
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1175-1181

Références

Arch Gen Psychiatry. 1965 Jan;12:63-70
pubmed: 14221692
BMJ. 2014 Feb 13;348:g1151
pubmed: 24524926
Addiction. 2010 Aug;105(8):1466-71
pubmed: 20528815
Psychiatry Clin Neurosci. 2000 Apr;54(2):169-72
pubmed: 10803811
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Behav Genet. 1995 Mar;25(2):95-101
pubmed: 7733862
Ear Nose Throat J. 1990 Nov;69(11):763-5
pubmed: 2276350
Rev Mal Respir. 2017 Mar;34(3):188-193
pubmed: 27743824
PLoS One. 2016 Jan 05;11(1):e0143490
pubmed: 26730716
Arch Gen Psychiatry. 1965 Dec;13(6):508-15
pubmed: 4378854
Arch Gen Psychiatry. 2003 Jul;60(7):692-700
pubmed: 12860773
Acta Oncol. 2003;42(2):154-9
pubmed: 12801134
Nicotine Tob Res. 2008 Dec;10(12):1691-715
pubmed: 19023823
NCHS Data Brief. 2010 Apr;(34):1-8
pubmed: 20604991
Addict Res Theory. 2016;24(1):48-53
pubmed: 27547173
Nihon Ronen Igakkai Zasshi. 2011;48(2):149-57
pubmed: 21778631
Circ J. 2011;75(1):185-9
pubmed: 21071876
Zhonghua Nei Ke Za Zhi. 2016 Nov 1;55(11):854-858
pubmed: 27801340
Am Fam Physician. 2000 Aug 1;62(3):579-84, 591-2
pubmed: 10950214
West J Med. 1999 May;170(5):265
pubmed: 18751143
J Manag Care Pharm. 2007 Nov;13(9 Suppl A):S12-5
pubmed: 18062737
J Affect Disord. 2016 Feb;191:94-9
pubmed: 26655118
Prev Med. 2008 May;46(5):451-6
pubmed: 18314186

Auteurs

Maki Komiyama (M)

Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Yuka Ozaki (Y)

Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Yusuke Miyazaki (Y)

Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Japan.

Akihiro Yasoda (A)

Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Hiromichi Wada (H)

Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Hajime Yamakage (H)

Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Noriko Satoh-Asahara (N)

Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Tatsuya Morimoto (T)

Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Japan.

Akira Shimatsu (A)

Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Yuko Takahashi (Y)

Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Koji Hasegawa (K)

Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH